Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The person has had a major limb amputation.
- The person is 18 years of age or older at the time of signing the consent form.
- The person is considered healthy enough to undergo surgery, in the treating doctor's opinion.
- At least one year has passed since the person's most recent amputation.
- The person experiences residual limb pain (pain in the remaining part of the limb) that rates 4 or higher on average on a 0–10 pain scale, measured after a baseline observation period.
- If the person has been prescribed medication for pain, the dose must have remained unchanged for at least one month before the screening visit.
- If the person has been receiving non-medication pain treatments — such as spinal cord stimulation, electrical nerve stimulation, or mirror therapy — those treatments must have ended at least one month before the screening visit.
- The person has had a stable, well-fitted prosthetic limb for at least one month before the screening visit.
- The person has a sufficient understanding of the language used in the study assessments, in the treating doctor's opinion.
Who may not be able to join:
- The person has a neurological condition or other health condition that affects how nerves heal or regenerate in the area to be treated.
- The person has an active infection in the remaining part of the amputated limb.
- The person has previously had specific nerve-related surgeries (called RPNI or TMR) on the nerve being treated to address pain after amputation.
- The person has a mental health condition (such as schizophrenia, paranoia, or psychosis), or has language difficulties or reluctance that make it hard to understand what taking part in the study involves.
- The person is already taking part in another clinical trial that the treating doctor considers could negatively affect participation in this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Max Ortiz Catalan, PhD, Prometei Pain Rehabilitation Center
Phone: +46708461065
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Residual limb pain intensity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.